Navigation Links
UCSB chemistry professor receives top military award for life-saving gauze
Date:8/12/2008

UC Santa Barbara Chemistry Professor Galen Stucky has been honored for his role in the development of a blood-clotting gauze that is helping save soldiers who suffer severe, life-threatening injuries in Iraq and Afghanistan.

The Department of Defense's Advanced Technology Applications for Combat Casualty Care Award was presented to Stucky August 11 during the opening ceremonies of the group's annual meeting in Florida. The ATACCC convention is the premier scientific meeting on the battlefield medical needs of the nation's soldiers and on recent advances in trauma surgery and medicine.

"I am very honored," said Stucky of the ATACCC award. "In retrospect, this project has meant more to me than any other that I've worked on for the past 40 years. The most important aspect of this work is the thought that it is providing life support that is needed on an immediate-response basis to both military and civilian personnel. For those who knowingly are in harm's way, it is particularly important."

Severe battlefield injuries present unique problems in stemming blood loss, which is the primary cause of combat deaths. Medics may have less than two minutes to stop blood loss before death is imminent. In 2004, Stucky and his colleagues were asked by the Office of Naval Research to work with Connecticut-based Z-Medica to improve its zeolite-based substance, QuikClot brand hemostatic agent, which promotes instant clotting and sealing of the wound until the injured can be taken to medical facilities. Adding to the task, the Navy wanted a solution within six months.

QuikClot, though effective in stanching blood flow, had the potential to cause second-degree burns around the wound. Stucky and his UCSB research team developed a "cooler formulation" of the product, eliminating the possibility of heat generation that existed in the first-generation formula. A Z-Medica team then created another "cooler" version of QuikClot that also maintains the product's clotting power. Stucky's team also created a QuikClot formulation with silver ions that provides enhanced clotting as well as antimicrobial properties to fight infection.

Stucky also discovered that an alternative simple substance, kaolin clay, not only eliminated the heat but added to the blood-clotting action.

"Kaolin clay has been used since the 1950s as an activating agent for a clotting test that medical doctors routinely perform," says graduate student April Sawvel, who worked on the project. "We tested it against the original zeolite-based granular QuikClot and discovered that it worked just as well, but without the large heat release associated with the original QuikClot formulation."

The latest generation of the product, QuikClot Combat GauzeTM brand, is now a medical gauze infused with nanoparticles of kaolin clay. It has been found to be 100 percent effective in careful testing performed at the Naval Medical Research Center. Z-Medica also markets a civilian version, QuikClot 1st ResponseTM, which is becoming standard equipment with emergency providers nationwide, and QuikClot Sport brand and QuikClot Sport Silver, which are available over the counter and becoming popular with outdoor adventurers.

"Combat Gauze has been selected by the Committee on Tactical Combat Casualty Care as the first-line product for hemorrhage control," Dr. Michael B. Given, program officer for Casualty Care and Management with the Office of Naval Research, said in a note commending Stucky on his work. "Navy and the Marine Corps are adopting Combat Gauze, as will the other Services since we all follow CoTCCC recommendations. So, well done."

"Here's a very, very simple, cost-effective solution that works. I feel strongly about the impact it will and can have for the military and for civilians of every age," Stucky said. "It's a wonderful example of how the university can effectively and directly contribute to solving real-life problems in meaningful ways."

Stucky said the next step is developing ways to stop internal bleeding. Imagine a successful, blood-borne process that would stem bleeding, say, in the case of a concussion. He and his team are planning to put their efforts into a new research project to tackle the problem. Meanwhile, QuikClot Combat GauzeTM is saving military and civilian lives all over the world.


'/>"/>

Contact: Marcia Meier
meier@research.ucsb.edu
805-893-7345
University of California - Santa Barbara
Source:Eurekalert

Related biology news :

1. Global Challenges/Chemistry Solutions debuts with focus on drinking water
2. Yales Anastas honored for leadership in founding of green chemistry
3. 14-year-old CEO makes chemistry a game with Elementeo
4. Agriculture is changing the chemistry of the Mississippi River
5. Story ideas from the Journal of Biological Chemistry
6. Biocapture surfaces produced for study of brain chemistry
7. Story ideas from the Journal of Biological Chemistry
8. Going live with click chemistry
9. Biogeochemistry -- A window into the Earths ecological health
10. K-State chemistry professor to receive Masao Horiba award
11. Chemistry turns killer gas into potential cure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:5/20/2016)... 20, 2016  VoiceIt is excited to announce ... By working together, VoiceIt and VoicePass ... and VoicePass take slightly different approaches to voice ... security and usability. ... new partnership. "This marketing and technology ...
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, ... Pennsylvania Convention Center and will showcase its product’s latest features from June 26 ... presenting a scientific poster on Disrupting Clinical Trials in The Cloud during the ...
(Date:6/23/2016)... , June 23, 2016 ... research report to its pharmaceuticals section with historic ... details and much more. Complete report ... 151 pages, profiling 15 companies and supported with ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global ...
Breaking Biology Technology: